MIAMI, Dec. 31, 2024 (GLOBE NEWSWIRE) — Ehave, Inc., (OTC Pink: EHVVF) (the “Company announced today that it has returned to current status on its filings with the U.S. Securities and Exchange Commission (SEC). Existing shareholders of Ehave, Inc. will find their shares quoted on the OTC Pink Market without needing to take any further action. This milestone reflects the company’s commitment to transparency and regulatory compliance, as well as its dedication to protecting shareholder value.
Ben Kaplan, CEO of Ehave, Inc., commented on the achievement, emphasizing his dedication to the company’s stakeholders: “I could have walked away from Ehave, but I felt a deep responsibility to fulfill my obligation to our shareholders. This accomplishment marks a turning point for Ehave, and I am confident that we are now positioned to move the Company in a new direction in 2025. Happy New Year to all our loyal and dedicated shareholders and thank you for your patience and support.”
The company’s renewed compliance with SEC reporting requirements underscores its focus on regaining investor trust and creating long-term value for shareholders.
For updates and more information about Ehave, Inc., please visit http://www.ehave.com.
Forward-Looking Statement Disclaimer
This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may be preceded by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or similar words. Forward-looking statements are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company’s control, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements: (i) the initiation, timing, progress and results of the Company’s research, manufacturing and other development efforts; (ii) the Company’s ability to advance its products to successfully complete development and commercialization; (iii) the manufacturing, development, commercialization, and market acceptance of the Company’s products; (iv) the lack of sufficient funding to finance the product development and business operations; (v) competitive companies and technologies within the Company’s industry and introduction of competing products; (vi) the Company’s ability to establish and maintain corporate collaborations; (vii) loss of key management personnel; (viii) the scope of protection the Company is able to establish and maintain for intellectual property rights covering its products and its ability to operate its business without infringing the intellectual property rights of others; (ix) potential failure to comply with applicable health information privacy and security laws and other state and federal privacy and security laws; and (x) the difficulty of predicting actions of the USA FDA and its regulations. All forward-looking statements included in this press release are made only as of the date of this press release. The Company assumes no obligation to update any written or oral forward-looking statement unless required by law. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is contained under the heading “Risk Factors” in Ehave, Inc.’s Registration Statement on Form F-1 filed with the Securities and Exchange Commission (SEC) on September 24, 2015, as amended, which is available on the SEC’s website, http://www.sec.gov.
For Media and Investor Relations, please contact:
David L. Kugelman
(866) 692-6847 Toll Free – U.S. & Canada
(404) 281-8556 Mobile and WhatsApp
Email: Ir@Ehave.com
Skype: kugsusa
